PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Dalteparin sodium - VTE prevention post hip/knee replacement
PAD Profile : Dalteparin sodium - VTE prevention post hip/knee replacement
Keywords :
VTE prophylaxis, venous thromboembolism, Low molecular weight heparins, LMWH, SWLEOC guidelines
Brand Names Include :
Fragmin
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
Other Indications
- Pre-operative / bridging therapy
- VTE prophylaxis
- VTE treatment in patients unable to take oral anticoagulants
- VTE treatment in pregnancy
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
27 October 2010
Not Set
The use of LMWH to prevent VTE post operatively is considered as red on the traffic light system. The full course of treatment should be supplied by the Acute Trust.
Associated BNF Codes
02. Cardiovascular System
02.08.01. Parenteral anticoagulants